Cisatracurium Besylate
- Product NDC
- 31722-313
- 11-digit product format
- 317220313
- Labeler code
- 31722
- Product ID
- 31722-313_da5bd5ef-99b7-449c-8b59-bb9eb2540d62
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cisatracurium Besylate
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Camber Pharmaceuticals Inc.
- Application
- ANDA212432
- Marketing category
- ANDA
- Marketing start
- 2026-05-04
- Substance
- CISATRACURIUM BESYLATE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cisatracurium Besylate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CISATRACURIUM BESYLATE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 80YS8O1MBS |
| Rxcui | 199211, 199212, 1730194 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 31722-313-02 | Cisatracurium Besylate | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION | 5 | | 2 |
| 31722-313-10 | Cisatracurium Besylate | 10 in 1 CARTON | INJECTION | 10 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 31722-313-02 | 31722031302 | 5 mL in 1 VIAL, SINGLE-DOSE | 5 ml | | | | Historical |
| 31722-313-10 | 31722031310 | 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-313-10) / 5 mL in 1 VIAL, SINGLE-DOSE (31722-313-02) | | 2026-05-04 | No | No | Historical |